MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma2005 · 7,503 citations
2. 2Clinical Trial Substantiates the Predictive Value of O-6-Methylguanine-DNA Methyltransferase Promoter Methylation in Glioblastoma Patients Treated with Temozolomide2004 · 792 citations
3. 3Methylation of Discrete Regions of the O 6 -Methylguanine DNA Methyltransferase (MGMT) CpG Island Is Associated with Heterochromatinization of the MGMT Transcription Start Site and Silencing of the Gene1997 · 218 citations
4. 4Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group.1995 · 369 citations
5. 5Phase I Trial of Temozolomide Plus O6-Benzylguanine for Patients With Recurrent or Progressive Malignant Glioma2005 · 290 citations